A urinary DNA methylation test showed potential for detecting high-grade or invasive bladder cancer, according to results of ...

"We were particularly pleased to see that these results are further supported by an exploratory sub-analysis including only ...

Discover how AI-based assays offer a promising approach to tailor treatment for high-risk non-muscle-invasive bladder cancer.

Two doses of a simple tuberculosis vaccination after surgery helps the immune system fight cancer cells and could greatly improve patient outcomes for ...

A propensity-score matched cohort study found a significantly reduced risk of recurrence of bladder cancer in patients who ...

Investigators employed artificial intelligence to characterize tissue samples of high-risk NMIBC that were likely to recur or progress after treatment with intravesical bacillus Calmette-Guérin (BCG).

We were particularly pleased to see that these results are further supported by an exploratory sub-analysis including only high-grade T1 bladder cancer patients. With such high rates of recurrence ...

Bladder cancer is characterized by the high rates of recurrence ... higher in Ta disease than in T1 disease (50 vs 30%). The rates are also affected by tumor grade, with 50% in G1 disease ...

Artificial intelligence (AI)-based histologic assays identify nonmuscle-invasive bladder ... 944 cases of high-risk NMIBC, high-grade Ta was diagnosed in 34.1%, high-grade T1 in 54.8%, carcinoma ...